AMERICAN INTERNATIONAL GROUP, INC. - STOKE THERAPEUTICS INC ownership

STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 99 filers reported holding STOKE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 1.0%.

Quarter-by-quarter ownership
AMERICAN INTERNATIONAL GROUP, INC. ownership history of STOKE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$54,242
-61.6%
13,767
+3.7%
0.00%
-100.0%
Q2 2023$141,135
+56.4%
13,277
+22.6%
0.00%0.0%
Q1 2023$90,239
-7.9%
10,833
+2.0%
0.00%0.0%
Q4 2022$97,995
-28.5%
10,617
-0.4%
0.00%0.0%
Q3 2022$137,000
-1.4%
10,656
+1.4%
0.00%0.0%
Q2 2022$139,000
-30.2%
10,506
+10.9%
0.00%0.0%
Q1 2022$199,000
-18.1%
9,477
-6.6%
0.00%0.0%
Q4 2021$243,000
-8.6%
10,144
-2.9%
0.00%0.0%
Q3 2021$266,000
-26.1%
10,448
-2.3%
0.00%0.0%
Q2 2021$360,000
+17.3%
10,696
+35.3%
0.00%0.0%
Q1 2021$307,000
-31.3%
7,906
+9.6%
0.00%
-50.0%
Q4 2020$447,000
+82.4%
7,212
-1.3%
0.00%
+100.0%
Q3 2020$245,000
+37.6%
7,305
-2.2%
0.00%0.0%
Q2 2020$178,000
-22.9%
7,471
-25.8%
0.00%0.0%
Q1 2020$231,000
+42.6%
10,069
+75.7%
0.00%0.0%
Q4 2019$162,000
+30.6%
5,732
-0.8%
0.00%0.0%
Q3 2019$124,0005,7800.00%
Other shareholders
STOKE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 296,822$9,991,0002.07%
RTW INVESTMENTS, LP 3,644,248$122,665,0001.85%
Cormorant Asset Management, LP 1,278,276$43,027,0001.46%
Redmile Group, LLC 2,458,558$82,755,0001.22%
SPHERA FUNDS MANAGEMENT LTD. 233,135$7,847,0000.53%
Birchview Capital, LP 15,000$505,0000.30%
Perceptive Advisors 1,343,956$45,238,0000.29%
GILDER GAGNON HOWE & CO LLC 1,245,956$41,939,0000.21%
Artal Group S.A. 250,000$8,415,0000.17%
Casdin Capital, LLC 120,000$4,039,0000.10%
View complete list of STOKE THERAPEUTICS INC shareholders